Previous report showed that the subjects with NAFLD had higher irisin levels than healthy ones [65], and these high levels have been suggested to act as a compensatory mechanism aimed at improving energy metabolism and insulin sensitivity [66]. The gene discussed is INS; the disease is metabolic dysfunction-associated steatotic liver disease.